MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a.
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company focused on developing innovative therapies for rare cancers, for the supply of the medical radioisotope no-carrier-added 177Lu (n.c.a. 177Lu).
Eczacıbaşı-Monrol entered the theranostic market in 2019 as one of the few producers of Lutetium-177 worldwide and since then has provided an uninterrupted supply of this critical product to patients in many countries. In line with its mission to improve the quality of life of cancer patients globally, the company is establishing strategic partnerships with international pharmaceutical companies and constructing a new production facility compliant with FDA 21 CFR Part 211 quality standards that will have an annual capacity of 60 thousand doses. Thanks to its location close to Istanbul's transportation hub, the new facility will benefit from a worldwide logistics network and agreements with cargo services to 320 destinations worldwide.
Aydin Küçük, General Manager of Eczacıbaşı-Monrol, noted that n.c.a.177Lu contributes to the company's mission of adding value to human life with leading and innovative approaches in the diagnosis and treatment of critical diseases and added, "To support our growth in this field, we're establishing a new GMP certified facility exclusively for theranostic R&D and production with a new technology that will enable us to maximize our supply of high-quality Lutetium. Sustainability and innovation are two of our core values, and we strive for continuous improvement in our operations and products while trying to serve patients all around the world."
Molecular Targeting Technologies, Inc. (MTTI) CEO, Chris Pak said, " We’ve identified a timely and sustainable supply of a key therapeutic ingredient needed for the development and launch of our lead asset 177Lu-EBTATE and other EB platform technologies. We are excited to start
this collaboration and build what promises to be a great relationship with a reliable and trusted radioisotope supply partner like Eczacıbaşı-Monrol for the supply of n.c.a.177Lu.”
About Molecular Targeting Technologies, Inc. (MTTI)
Molecular Targeting Technologies, Inc. is a privately held, rapidly growing, well financed, clinical stage biotech developing targeted radiotherapeutics and diagnostics for rare cancers. We are committed to building value by acquiring and translating innovative imaging, radiopharmaceutical and theranostic assets to improve human health, reduce healthcare costs and reward stakeholders. MTTI expects to be orchestrating multiple clinical trials in 2022. For more information: www.mtarget.com; www.evathera.com
About Eczacıbaşı-Monrol
Eczacıbaşı-Monrol Nuclear Products Co. is an innovative, international supplier of radiopharmaceuticals for diagnosis and treatment in nuclear medicine. Eczacıbaşı-Monrol is headquartered in Istanbul and delivers customer-oriented service globally.
Monrol exports high quality and a wide spectrum of nuclear medicine products to more than 50 countries around the globe and has manufacturing sites and operational projects in different regions. For more information visit www.monrol.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123006032/en/
Contact information
MTTI
Mr. Chris Pak
President & CEO
Email:cpak@mtarget.com
Eczacıbaşı Monrol
Mr. Aydın Küçük
General Manager
Email: aydin.kucuk@monrol.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global Statement on Shell Arbitration Decision12.8.2025 23:51:00 EEST | Press release
Today, Venture Global issued the following statement in response to the positive tribunal decision on the arbitration proceeding with Shell: “We are pleased with the tribunal’s determination which reaffirms what Venture Global has maintained from the outset--the plain language in our contracts, mutually agreed upon with all of our customers, is clear. We have consistently honored these agreements without exception. Our industry and the investors and lenders who underpin it, all rely on respect for both the sanctity of negotiated contracts and the experienced, objective regulatory and legal bodies that govern it. These principles will ensure our industry remains dynamic, fair and competitive, enabling the innovation and breakthroughs that benefit all market participants and the customers we serve. Venture Global’s unique ability to incrementally export commissioning cargoes during the construction of our facilities has brought LNG to the market years faster than ever before and strength
Celonis Named a Leader in Process Intelligence Software12.8.2025 19:18:00 EEST | Press release
Celonis, a global leader in Process Mining, today announced it has been named a Leader in The Forrester Wave™: Process Intelligence Software, Q3 2025. According to the report, “Celonis is best suited to clients looking for a sophisticated platform that supports enterprise-wide process intelligence and control to transform operations.” Forrester also cited Celonis’ trailblazing role in the category, noting its early adoption of graph databases, an additional object-centric view of process performance, and an extended marketplace of partner-built solutions. “We are honored to be named a Leader in The Forrester Wave: Process Intelligence. This recognition is only possible because of the dedication and commitment of our customers, partners and Celonauts,” said Carsten Thoma, President and Board Director, Celonis. “Enterprise AI is set to reinvent operations. To deliver on its full potential, AI needs to understand how each business runs and how to make it run better. Our Process Intelligen
Empowering Developers to Monetize Anywhere: Xsolla Expands Platform Support for Cross-Platform Direct-to-Consumer Commerce12.8.2025 19:00:00 EEST | Press release
Xsolla, a global commerce company helping developers launch, grow, and monetize their games, announces today a major expansion of its platform support capabilities, reinforcing its position as the premier provider of cross-platform monetization solutions for developers. With the latest SDKs for Windows Stores and the Epic Games Store, a new strategic partnership with Pley, and the launch of the Xsolla Discord Bot, developers can now implement secure, streamlined commerce across PC, mobile, web, and community platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812673202/en/ (Graphic: Xsolla) Key Platform Expansions Now Available to Developers: SDK for Windows stores PC developers can access flexible monetization tools via Xsolla SDK for Windows Stores, offering seamless checkout flows and cross-platform SKU synchronization for multiplatform titles available on Windows across a variety of game stores. Setup is streaml
Andersen Consulting Expands Digital Transformation Solutions with Future Processing12.8.2025 16:30:00 EEST | Press release
Andersen Consulting announces a Collaboration Agreement with Future Processing, a technology and software consultancy, strengthening the organization’s ability to deliver end-to-end digital solutions. Founded in 2000 in Poland, Future Processing has been successfully delivering advanced IT projects for clients worldwide for over two decades. The company provides a full spectrum of services based on extensive technological expertise and advisory capabilities—from consulting and digital product strategy to custom software development, cloud, data, AI, machine learning, and cybersecurity solutions. Their expertise enables clients to adopt AI, migrate and integrate systems, modernize and scale cloud infrastructure, optimize and manage IT operations, and execute performance-led engineering initiatives. “Through our collaboration with Andersen Consulting, we advance our mission to deliver technology solutions at scale,” said Michał Sztanga, managing director of Future Processing. “Together,
Unity Game Developers Can Now Enable Direct-to-Consumer Monetization With Xsolla’s New SDK12.8.2025 16:00:00 EEST | Press release
Xsolla, a global commerce company helping developers launch, grow, and monetize their games, today announces the launch of an SDK for Unity that expands monetization capabilities for developers using the Unity engine. This new SDK is a part of Xsolla’s continued mission to unlock direct-to-consumer revenue opportunities across all platforms - mobile, PC, and the web - without complex backend work. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812923531/en/ (Graphic: Xsolla) Whether building a mobile-first title, a PC game, or a browser-based game, Unity developers can now integrate payments, enable in-game purchases, and create custom storefronts without relying on closed platforms. With a fast time-to-market, developers can start selling directly to their players and retain more of their revenue from day one, while maintaining full ownership of the checkout experience, player data, and monetization strategy. Key benefit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom